In addition to the Pilot Programs, CWRU’s CTSC regularly solicits proposals for other funding opportunities from NIH’s National Center for Advancing Translational Sciences (NCATS) throughout the year. Some current opportunities are described below. These lists are regularly reviewed and updated.
Overview of FY 2025 HHS Budget: Executive Summary
National Center for Advancing Translational Sciences (NCATS)
PAR-23-177 Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed). Next due date: June 19, 2025
RFA-TR-25-002 Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) Next due date: June 02, 2025
PAR-25-217 Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed). Next due date: February 03, 2025
PAR-25-220 Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) Next due date : February 03, 2025
PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp—Clinical Trial Not Allowed). Due dates vary by awarding institute or center.
RFA-TR-24-023: Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed). June 02, 2025
See a full list of NCATS funding opportunities
Special Interest
NOT-OD-25-015: Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
NOT-NR-25-003: Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
NOT-TR-24-017: Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program T32/TL1 Institutional Training Program as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
NOT-OD-24-079: Notice of Special Interest: Women’s Health Research
NOT-OD-24-179: Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
NOT-DK-24-029 Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed)
See a full list of NIH Medical Research Initiatives
With particular interest to Northern Ohio
PAR-25-298 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) Next due date: February 25, 2025
RFA-NR-25-002 NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed) January 28, 2025
PAR-25-098: Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required). Next due date: February 05, 2025.
PAR-24-059: Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional). Next due date: February 05, 2025.
RFA-AI-24-068: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed). Due date January 31, 2025
Addiction/Pain Management
NOT-DA-25-032 Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs), First available due date: February 05, 2025
PA-21-180: Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) Next due date: February 16, 2025
RFA-DA-26-056 Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed). Next due date: July 17, 2025
RFA-OD-25-001 High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional). Next due date: June 06, 2025
RFA-NS-25-020: HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional). Next due date: February 06, 2025.
RFA-NS-22-034: HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed). Next due date: December 07, 2024
RFA-NS-25-020: HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional). Due date: February 06, 2025.
RFA-NS-24-021: HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 Clinical Trial Optional). Next due date February 6, 2025
PAR-24-197: HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) Next due date: October 16, 2024, February 16, 2025
RFA-NS-23-006: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed). Next due date: March 4, 2025
Cancer
Case Comprehensive Cancer Center Funding Page
NIH National Cancer Institute Grants and Funding Page
Chronic Conditions
PAR-24-280 Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed). Next due date March 04, 2025
RFA-DK-25-016 Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed) November 14, 2024
Communication Disorders
RFA-DC-24-001. BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required). Next due date September 19, 2025
PAR-24-166. Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education Experiences and/or Mentoring Networks (R25 - Independent Clinical Trial Not Allowed). Next due date September 29, 2025
Community-Engaged Research
PAR-25-292: The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional). Next due date February 05, 2025
PAR-22-210. Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional). Next due date October 05, 2024, February 05, 2025
COVID-19
PAR-24-203. Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed). Next due date October 04, 2024, February 05, 2025
Dissemination and Implementation Research
PAR-25-143 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional). Next Due date: February 16, 2025
PAR-25-233 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed). Next due date: February 16, 2025
PAR-25-144 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional), Next due date February 05, 2025
Diabetes
PAR-24-094. NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) Next due date October 09, 2024, June 10, 2025. Associated links: PAR-24-102 , U01 Research Project (Cooperative Agreements); PAR-24-103 , U01 Research Project (Cooperative Agreements)
*PAR-23-119. Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed). Next due date October 16, 2024, Associated links: PAR-23-293 (R01 Clinical Trial Optional), PAR-23-294 (R21 Clinical Trial Optional) and PAR-23-295 (R03 Clinical Trial Optional)
Environmental Health
RFA-MD-24-010: Environmental Health Disparities Centers (P50) Clinical Trial Optional. Due date: December 05, 2024
RFA-ES-22-002: Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional). November 01, 2024
PAR-22-210: Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional). Next due date October 5, 2024, February 5, 2025
PAR-23-294. Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional). Next due date October 21, 2024, February 20, 2025
Genomics
PAR-23-132: NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed). Next due date October 16, 2024, February 16, 2025
PAR-24-241: Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U24 Clinical Trial Not Allowed) Companion grant: PAR-24-240, U01 Research Project (Cooperative Agreements). June 13, 2025
Health Equity
National Institute on Minority Health and Health Disparities Funding Opportunities
PAR-25-207 Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required). Next due date: February 05, 2025
PAR-24-231 Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional). October 5, 2026.
PAR-24-281 NLM Information Resource Grants to Reduce Health Disparities and Promote Health Equity (G08 Clinical Trial Not Allowed). December 13, 2024
RFA-AA-006: Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required). Due date October 18, 2024, February 19, 2025
RFA-EB-21-001: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional). Next due date January 21, 2025
PAR-22-145: Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional). Next due date October 5, 2024, February 05, 2025
Integrative Medicine: NCCIH
PAR-25-267 NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required). Next due date: February 20, 2025
NOT-DA-25-032 Notice of Special Interest (NOSI): Discovery and Development of Natural Products to Treat Substance Use Disorders (SUDs), First available due date: February 05, 2025
PAR-25-210: Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional). Next due date June 02, 2025
PAR-25-211: Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional). Next due date June 02, 2025
PAR-24-083: NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required). Associated links: PAR-24-083, R01 Research Project, PAR-24-086 , R01 Research Project
PAR-24-087, U24 Resource-Related Research Project (Cooperative Agreements)
PAR-24-090, UG3/ UH3 Phase 1 Exploratory/Developmental Cooperative Agreement/Exploratory/Developmental Cooperative Agreement Phase II, Due date October 21, 2024, February 20, 2025
See a full list of NCCIH funding opportunities
KL2 Scholars
--
Maternal and Child Health
PAR-23-130: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional). Next due date October 5, 202, February 05, 2025
PAR-23-131: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional). Next due date October 16, 2024, February 16, 2025
PAR-24-059. Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional). Next due date October 05, 2024, February 05, 2025
Mental Health
RFA-MH-25-206: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional). Next due date: January 28, 2025.
RFA-MH-25-205: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional). Next due date: January 28, 2025
PAR-25-206: Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required). Next due date: February 05, 2025
PAR-22-155: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional). Next due date June 9, 2025.
Multimorbidity
--
Rare Diseases
PAR-25-122 Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed). Next due February 16, 2025
Research Education
PAR-23-030: Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32). Next due date January 25, 2025.
Translational Science
PAR-25-115: Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional). Due date February 16, 2025
PAR-25-116: Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional). Next due date: February 05, 2025
PAR-23-200: National Eye Institute Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed). Next due date February 16, 2025
Veterans Administration
--
Private Foundations or Non-Profits
PCORI: Patient-Centered Outcomes Research Institute (PCORI)
Hope Foundation for Cancer Research
Lung Cancer Foundation of America. Membership required.
Robert Wood Johnson Foundation
*Are the last date in the notice for funding.
Search for Funding
Pilot Program funding should lead to funding from government agencies and private foundations. Explore the links below to find the right funding opportunities to take your Pilot Project to the next stage.
| NIH | NIH is the world’s largest funder of biomedical research. Search NIH’s funding list and learn about grants and other resources. |
| National Science Foundation | Browse the NSF’s current funding opportunities. |
| Department of Defense | The Congressionally Directed Medical Research Program has a variety of funding opportunities focused on transforming healthcare through innovative and impactful research. |
| Grants.gov |
Grants.gov is a centralized location for grant seekers to find and apply for funding opportunities from all departments of the federal government. |
| Foundations | CWRU subscribes to Pivot, a service available to all faculty, staff researchers, and graduate students that helps you quickly discover the right funding opportunities. Follow the link above for the Office of Research & Grant Development’s quick start guide. |